[go: up one dir, main page]

AU2001228488A1 - Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels - Google Patents

Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels

Info

Publication number
AU2001228488A1
AU2001228488A1 AU2001228488A AU2848801A AU2001228488A1 AU 2001228488 A1 AU2001228488 A1 AU 2001228488A1 AU 2001228488 A AU2001228488 A AU 2001228488A AU 2848801 A AU2848801 A AU 2848801A AU 2001228488 A1 AU2001228488 A1 AU 2001228488A1
Authority
AU
Australia
Prior art keywords
modulate
activity
hyperpolarisation
cation channels
identifying substances
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2001228488A
Inventor
Andrea Bruggemann
Heinz Gogelein
Holger Heitsch
Hans-Willi Jansen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis Deutschland GmbH
Original Assignee
Aventis Pharma Deutschland GmbH
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aventis Pharma Deutschland GmbH filed Critical Aventis Pharma Deutschland GmbH
Publication of AU2001228488A1 publication Critical patent/AU2001228488A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6872—Intracellular protein regulatory factors and their receptors, e.g. including ion channels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2503/00—Use of cells in diagnostics
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2500/00—Screening for compounds of potential therapeutic value

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Molecular Biology (AREA)
  • Chemical & Material Sciences (AREA)
  • Cell Biology (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Urology & Nephrology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Physics & Mathematics (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Cardiology (AREA)
  • Veterinary Medicine (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
  • Measurement And Recording Of Electrical Phenomena And Electrical Characteristics Of The Living Body (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The present invention provides a process for identifying substances that modulate the activity of hyperpolarization-activated cation channels, and the use of this process.
AU2001228488A 2000-02-12 2001-01-24 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels Abandoned AU2001228488A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10006309A DE10006309A1 (en) 2000-02-12 2000-02-12 Method for the identification of substances that modulate the activity of hyperpolarization-activated cation channels
DE10006309 2000-02-12
PCT/EP2001/000755 WO2001059153A2 (en) 2000-02-12 2001-01-24 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels

Publications (1)

Publication Number Publication Date
AU2001228488A1 true AU2001228488A1 (en) 2001-08-20

Family

ID=7630723

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2001228488A Abandoned AU2001228488A1 (en) 2000-02-12 2001-01-24 Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels

Country Status (9)

Country Link
US (2) US6979532B2 (en)
EP (1) EP1257819B1 (en)
JP (1) JP4782967B2 (en)
AT (1) ATE403864T1 (en)
AU (1) AU2001228488A1 (en)
DE (2) DE10006309A1 (en)
DK (1) DK1257819T3 (en)
ES (1) ES2311529T3 (en)
WO (1) WO2001059153A2 (en)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020144905A1 (en) 1997-12-17 2002-10-10 Christian Schmidt Sample positioning and analysis system
US7244349B2 (en) 1997-12-17 2007-07-17 Molecular Devices Corporation Multiaperture sample positioning and analysis system
US7067046B2 (en) 2000-08-04 2006-06-27 Essen Instruments, Inc. System for rapid chemical activation in high-throughput electrophysiological measurements
US7270730B2 (en) 2000-08-04 2007-09-18 Essen Instruments, Inc. High-throughput electrophysiological measurement system
WO2002098287A2 (en) * 2001-06-06 2002-12-12 The Trustees Of Columbia University In The City Of New York A high throughput biological heart rate monitor that is molecularly determined
US7794702B2 (en) * 2003-01-15 2010-09-14 The Trustees Of Columbia University In The City Of New York Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures
US20050002914A1 (en) * 2003-01-15 2005-01-06 Rosen Michael R. Mesenchymal stem cells as a vehicle for ion channel transfer in syncytial structures
GB0303506D0 (en) * 2003-02-14 2003-03-19 Novartis Ag Organic compounds
US8859273B2 (en) * 2003-12-24 2014-10-14 Medtronic, Inc. Methods of using HCN genes to treat cardiac arrhythmias
US20090029366A1 (en) * 2007-03-28 2009-01-29 Wyeth Methods of identifying modulators of hyperpolarization-activated cyclic nucleotide-gated (hcn) channels
WO2011106198A1 (en) 2010-02-23 2011-09-01 Christopher Gordon Atwood Methods for the detection of biologically relevant molecules and their interaction characteristics
US20110319478A1 (en) * 2010-06-04 2011-12-29 Medtronic, Inc. Compositions to Treat Cardiac Pacing Conditions
US8905342B2 (en) 2011-11-30 2014-12-09 Whirlpool Corporation Food processing device with lid mounted adjustment mechanism
US8814072B2 (en) 2011-11-30 2014-08-26 Whirlpool Corporation User-controlled adjustment mechanism for a food processing device
US8899504B2 (en) 2011-11-30 2014-12-02 Whirlpool Corporation Externally-operated adjustment mechanism for a food processing device
US8833683B2 (en) 2012-03-08 2014-09-16 Whirlpool Corporation Food processor with external control for operating an adjustable cutting tool
CN116656770A (en) * 2023-04-21 2023-08-29 中国药科大学 Cell water loss model and establishment method and application thereof

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5882873A (en) * 1993-02-19 1999-03-16 Pharmacia & Upjohn Company Human DNA sequence encoding a kidney ATP-dependent potassium channel
DE19621312A1 (en) * 1996-05-28 1997-12-04 Bayer Ag Masking of background fluorescence and signal amplification in the optical analysis of biological medical assays
GB9718365D0 (en) * 1997-08-29 1997-11-05 Univ London Ion channel proteins
US6703485B2 (en) 1997-12-23 2004-03-09 The Trustees Of Columbia University In The City Of New York Brain and heart cyclic nucleotide gated ion channel compounds and uses thereof
DE19806581A1 (en) 1998-02-17 1999-10-21 Forschungszentrum Juelich Gmbh Ih ion channel sequences and their use
WO2000063349A1 (en) * 1999-04-15 2000-10-26 Icagen, Inc. Human hac3
WO2000073431A2 (en) * 1999-05-27 2000-12-07 Pharmacia & Upjohn Company Methods and compositions for measuring ion channel conductance
US20090029366A1 (en) * 2007-03-28 2009-01-29 Wyeth Methods of identifying modulators of hyperpolarization-activated cyclic nucleotide-gated (hcn) channels

Also Published As

Publication number Publication date
WO2001059153A2 (en) 2001-08-16
ES2311529T3 (en) 2009-02-16
US20030082513A1 (en) 2003-05-01
DE50114193D1 (en) 2008-09-18
EP1257819B1 (en) 2008-08-06
JP2003522533A (en) 2003-07-29
US7550257B2 (en) 2009-06-23
ATE403864T1 (en) 2008-08-15
JP4782967B2 (en) 2011-09-28
DE10006309A1 (en) 2001-08-23
US6979532B2 (en) 2005-12-27
WO2001059153A3 (en) 2002-04-11
DK1257819T3 (en) 2009-01-19
US20070231849A1 (en) 2007-10-04
EP1257819A2 (en) 2002-11-20

Similar Documents

Publication Publication Date Title
AU2001228488A1 (en) Method for identifying substances which modulate the activity of hyperpolarisation-activated cation channels
AU2002365508A1 (en) Apparatus and method for modification of magnetically immobilized biomolecules
AU2002345497A1 (en) Cips as modifiers of the p53 pathway and method of use
WO2003002717A3 (en) Biological activity of ak155
AU2002318477A1 (en) Method and apparatus for peer-to-peer services
WO1999054286A3 (en) Btk inhibitors and methods for their identification and use
EP1700120A4 (en) Marker for neuromyelitis optica
WO1999019513A3 (en) Methods for detecting compounds which modulate the activity of an lpa receptor
AU2003300817A1 (en) Modulating immune responses
GB2377295A (en) Conversational dealing system
MY125565A (en) Intermediates and process for preparing olanzapine
NZ320259A (en) Deodorizing preparations containing cationic biopolymers, aluminium hydrochlorate and esterase inhibitors
DE69712878D1 (en) Phosphatasemodulator
AU2001294895A1 (en) Methods for identifying compounds that modulate biofilm activity
WO2002055725A3 (en) Novel nucleic acids, methods and transformed cells for the modulation of gibberellin production
CA2349529A1 (en) Pge synthase and methods and means for modulating its activity
AR027327A1 (en) PROCEDURE FOR THE EINZYMATIC SEPARATION OF AMINOMETIL-ARIL-CICLOHEZANOL DERIVATIVES
AU2003211040A1 (en) The eaat2 promoter and uses thereof
MXPA04010915A (en) Dynamic human resources knowledge base and process.
AU2002326018A1 (en) Assay for identifying ion channel modulators
MXPA01008214A (en) Inhibitors of separin, method for identifying them and uses.
WO2001012838A3 (en) Compounds which modulate the activity of an lpa receptor
AU1653100A (en) Use of diminazene-di-aceturate for treating malaria
WO2001020335A3 (en) Methods for modulating cell proliferation
WO2004065932A3 (en) Methods of identifying modulators of cellular glycosylation using gtrap3-18